Clinical Sites
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
400
NCT02373293
Study to Assess the Prognostic Value of the Antithrombin III in the Acute Pancreatitis (AT-PROPANC)
Phase: N/A
Role: Collaborator
Start: Jan 18, 2015
Completion: Aug 31, 2017
Loading map...